Upload Avatar (500 x 500)
Jun Jie Xu
Medical School
Zhejiang University
Zhejiang
Language: English, Chinese
Liver Cancer
Gallbladder Cancer
Minimally Invasive
Precision Diagnosis
Drug Resistance
Metastasis
Translational Research
Immune Microenvironment
Metabolic Microenvironment
Targeted Therapy
Areas of Focus
- Minimally invasive precision diagnosis and treatment of malignant tumors of the liver and gallbladder
- Mechanisms and translational research of drug resistance and metastasis of malignant tumors of the liver and gallbladder
- Immune metabolic microenvironment of liver cancer
Work Experience
- 2022/12-Present - Zhejiang University School of Medicine - Distinguished Researcher
- 2022/07-Present - Zhejiang University School of Medicine Affiliated Sir Run Run Shaw Hospital - Assistant Director of Research Office
- 2022/06-Present - Zhejiang University School of Medicine - Deputy Director of Research Office (Concurrent)
- 2021/03-2022/02 - National Natural Science Foundation of China Medical Science Department - Part-time
- 2019/07-Present - Zhejiang University School of Medicine Affiliated Sir Run Run Shaw Hospital - Attending Physician
- 2018/08-2019/06 - Zhejiang University School of Medicine Affiliated Sir Run Run Shaw Hospital - Resident Physician
- 2018/07-2018/08 - University of Hong Kong Mary Hospital - Clinical Visiting Scholar
Academic Background & Achievements
- 2019/03-2022/03 Clinical Medicine Postdoc: Zhejiang University, Supervisor: Xiu Jun Cai
- 2013/09-2018/06 Minimally Invasive Medicine PhD: Zhejiang University, Supervisor: Xiu Jun Cai
- 2014/03-2015/07 Visiting Scholar: University of Rochester Medical Center
- 2008/09-2013/06 Clinical Medicine Bachelor's: Shanghai Jiao Tong University
- Published over 30 SCI papers with more than 1500 citations
- H-index of 21 on Google Scholar
- First or corresponding author of 23 SCI papers
Publications
- Sig Transduct Target Ther (2020 Cover Article, 2021 Cover Article/Highly Cited Paper, IF: 38.104), Jun Jie Xu, 2020
- Mol Cancer (2020, IF: 41.444), Jun Jie Xu, 2020
- EBioMedicine (2016, 2020, IF: 11.205), Jun Jie Xu, 2020
- Am J Gastroenterol (2021, IF: 12.045), Jun Jie Xu, 2021
- Cancer Letters (2024, IF: 9.7), Jun Jie Xu, 2024
- Cell Mol Gastroenterol Hepatol (2021, IF: 9.225), Jun Jie Xu, 2021
- J Exp Clin Cancer Res (2023, IF: 11.3), Jun Jie Xu, 2023
- Sci China Life Sci (2022, IF: 10.372), Jun Jie Xu, 2022
- Int J Cancer (2017, 2018, IF: 7.396), Jun Jie Xu, 2018
- Theranostics (2020, IF: 11.6), Jun Jie Xu, 2020
- Int J Biol Sci (2023, 2023, IF: 9.2), Jun Jie Xu, 2023
Awards
- Zhejiang Province Ten Thousand Talents Program Young Top Talent
- Member of EASL, AASLD, CSCO
- Committee Member of the Hepatobiliary Branch of the Chinese Medical Association of European and American Alumni Association
